Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […]
Hikma Pharmaceuticals (LON:HIK – Free Report) had its target price increased by Berenberg Bank from GBX 1,960 ($24.86) to GBX 2,000 ($25.37) in a research report released on Monday, Digital Look reports. The firm currently has a hold rating on the stock. Separately, Royal Bank of Canada restated a sector perform rating and issued a […]
Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has received a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target […]